DALLAS BONDHUS: Open Payments
NPI 1205826187 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,838 in 176 payments from 22 companies in 2025. Trend: 2023 $2,449 · 2024 $2,701 · 2025 $3,838
Food & beverage: $3,806Speaker / faculty: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $727 |
| UCB, Inc. | 17 | $584 |
| MDD US Operations, LLC | 20 | $314 |
| PFIZER INC. | 18 | $265 |
| ARGENX US, INC. | 10 | $210 |
| Lilly USA, LLC | 6 | $203 |
| Biogen, Inc. | 7 | $175 |
| Lundbeck LLC | 10 | $170 |
| Eisai Inc. | 4 | $170 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $152 |
Products named: QULIPTA, Zilbrysq, NURTEC ODT, Rystiggo, UBRELVY, VYVGART HYTRULO, Leqembi, BOTOX.
Industry payments across AR — which companies pay providers there.
